Also trades as: 2126.HK (HKSE) · $vol 0M
JWCTF OTC
JW (Cayman) Therapeutics Co. Ltd
1W: +0.0%
1M: +0.0%
3M: -14.8%
YTD: -43.8%
1Y: -58.9%
3Y: -56.6%
$0.20
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$987M
-41.2% ▼
5Y CAGR: -23.5%
Total Liabilities
$431M
-15.7% ▼
5Y CAGR: +4.3%
Shareholders Equity
$557M
-52.4% ▼
5Y CAGR: -30.5%
Cash & Investments
$503M
-33.5% ▼
5Y CAGR: -28.2%
Total Debt
$263M
-37.8% ▼
5Y CAGR: +16.3%
Net Debt
-$241M
+28.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.8B | $1.4B | $1.0B | $757M | $503M |
| Short-Term Investments | $695K | $6M | $6M | $0 | $0 |
| Cash & ST Investments | $1.8B | $1.4B | $1.0B | $757M | $503M |
| Net Receivables | $3M | $5M | $0 | $0 | $0 |
| Inventory | $31M | $40M | $35M | $31M | $62M |
| Other Current Assets | $26M | $51M | $4M | $13M | $5M |
| Total Current Assets | $1.9B | $1.5B | $1.1B | $809M | $571M |
| Property, Plant & Equip. | $381M | $393M | $341M | $276M | $211M |
| Goodwill & Intangibles | $816M | $894M | $711M | $590M | $199M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $24M | $19M | $26M | $6M | $8M |
| Total Non-Current Assets | $1.2B | $1.3B | $1.1B | $872M | $417M |
| Total Assets | $3.1B | $2.8B | $2.1B | $1.7B | $987M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $8M | $3M | $2M | $34M |
| Short-Term Debt | $5M | $142M | $105M | $362M | $226M |
| Deferred Revenue | $2M | $1M | $0 | $0 | $33M |
| Other Current Liabilities | $17M | $10M | $39M | $39M | $85M |
| Total Current Liabilities | $199M | $311M | $264M | $465M | $395M |
| Long-Term Debt | $95M | $92M | $158M | $20M | $18M |
| Other Non-Current Liab. | -$32M | -$34M | $0 | $0 | $0 |
| Total Non-Current Liabilities | $95M | $92M | $198M | $46M | $36M |
| Total Liabilities | $326M | $437M | $462M | $511M | $431M |
| — Equity — | |||||
| Common Stock | $27K | $27K | $27K | $27K | $27K |
| Retained Earnings | -$3.4B | -$4.2B | -$5.0B | -$5.6B | -$6.1B |
| Accumulated OCI | $61M | $471M | $568M | $644M | $0 |
| Total Stockholders Equity | $2.8B | $2.4B | $1.7B | $1.2B | $557M |
| Total Liabilities & Equity | $3.1B | $2.8B | $2.1B | $1.7B | $987M |
| — Key Metrics — | |||||
| Total Debt | $147M | $279M | $319M | $422M | $263M |
| Net Debt | -$1.7B | -$1.1B | -$687M | -$335M | -$241M |
| Total Investments | $695K | $6M | $6M | $0 | $0 |